Therefore, to delineate CHMP5’s contribution to oncogene-specific chemoresistance we assessed the impact of CHMP5 deficiency on CUTLL1 T-ALL cells response to GSI+Dex treatment. Here, CHMP5 is linked to acute lymphoblastic leukemia.